Ivabradina Pharmakern

Ivabradine, the active ingredient in Ivabradina Pharmakern, is a selective sinus node If channel inhibitor presented as an oral formulation for oral use. It lowers heart rate without affecting myocardial contractility or blood pressure and is employed in the management of chronic stable angina and heart failure with reduced ejection fraction.

GNH USA supplies Ivabradina Pharmakern as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide to meet diverse therapeutic needs, with reliable logistics and regulatory support.

Ivabradine is used to manage conditions where reduction of heart rate improves clinical outcomes.

Chronic stable angina pectoris: reduces frequency of angina attacks and improves exercise tolerance. Heart failure with reduced ejection fraction (in combination with beta‑blockers): lowers heart rate and may improve symptoms and functional capacity. Elevated resting heart rate in patients on optimal therapy: helps achieve target heart rate when other agents are insufficient.